Efficacy and safety of the activin signalling inhibitor, sotatercept, in a pooled analysis of PULSAR and STELLAR studies
GRAPHICAL ABSTRACT Overview of the study. # : p<0.001 for comparison of sotatercept with placebo on the basis of aligned-rank stratified Wilcoxon test, stratified according to randomisation factors of background therapy (monotherapy or dual therapy versus triple therapy) and baseline World Health...
Gespeichert in:
| Hauptverfasser: | , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
6 May 2025
|
| In: |
European clinical respiratory journal
Year: 2025, Jahrgang: 65, Heft: 5, Pages: 1-15 |
| ISSN: | 2001-8525 |
| DOI: | 10.1183/13993003.01424-2024 |
| Online-Zugang: | Verlag, kostenfrei, Volltext: https://doi.org/10.1183/13993003.01424-2024 Verlag, kostenfrei, Volltext: https://publications.ersnet.org/content/erj/65/5/2401424 
|
| Verfasserangaben: | Marius M. Hoeper, Mardi Gomberg-Maitland, David B. Badesch, J. Simon R. Gibbs, Ekkehard Grünig, Grzegorz Kopeć, Vallerie V. McLaughlin, Gisela Meyer, Karen M. Olsson, Ioana R. Preston, Stephan Rosenkranz, Rogerio Souza, Aaron B. Waxman, Loïc Perchenet, James Strait, Aiwen Xing, Solaiappan Manimaran, Xuelong Wang, Barry Miller, Alexandra G. Cornell, Janethe de Oliveira Pena, H. Ardeschir Ghofrani and Marc Humbert |
MARC
| LEADER | 00000naa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1940128145 | ||
| 003 | DE-627 | ||
| 005 | 20251104094349.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 251104s2025 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1183/13993003.01424-2024 |2 doi | |
| 035 | |a (DE-627)1940128145 | ||
| 035 | |a (DE-599)KXP1940128145 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Höper, Marius |d 1963- |e VerfasserIn |0 (DE-588)130336408 |0 (DE-627)498447251 |0 (DE-576)298134691 |4 aut | |
| 245 | 1 | 0 | |a Efficacy and safety of the activin signalling inhibitor, sotatercept, in a pooled analysis of PULSAR and STELLAR studies |c Marius M. Hoeper, Mardi Gomberg-Maitland, David B. Badesch, J. Simon R. Gibbs, Ekkehard Grünig, Grzegorz Kopeć, Vallerie V. McLaughlin, Gisela Meyer, Karen M. Olsson, Ioana R. Preston, Stephan Rosenkranz, Rogerio Souza, Aaron B. Waxman, Loïc Perchenet, James Strait, Aiwen Xing, Solaiappan Manimaran, Xuelong Wang, Barry Miller, Alexandra G. Cornell, Janethe de Oliveira Pena, H. Ardeschir Ghofrani and Marc Humbert |
| 264 | 1 | |c 6 May 2025 | |
| 300 | |b Diagramme | ||
| 300 | |a 15 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 04.11.2025 | ||
| 520 | |a GRAPHICAL ABSTRACT Overview of the study. # : p<0.001 for comparison of sotatercept with placebo on the basis of aligned-rank stratified Wilcoxon test, stratified according to randomisation factors of background therapy (monotherapy or dual therapy versus triple therapy) and baseline World Health Organization functional class (WHO FC) (II versus III); ¶ : p<0.001 for comparison of sotatercept with placebo on basis of a Cochran–Mantel–Haenszel method, stratified according to randomisation factors. 6MWD: 6-min walk distance; PAH: pulmonary arterial hypertension; PVR: pulmonary vascular resistance. | ||
| 700 | 1 | |a Gomberg-Maitland, Mardi |e VerfasserIn |4 aut | |
| 700 | 1 | |a Badesch, David B. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Gibbs, J. Simon R. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Grünig, Ekkehard |e VerfasserIn |0 (DE-588)112535801 |0 (DE-627)618892605 |0 (DE-576)31856694X |4 aut | |
| 700 | 1 | |a Kopeć, Grzegorz |e VerfasserIn |4 aut | |
| 700 | 1 | |a McLaughlin, Vallerie V. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Meyer, Gisela |e VerfasserIn |4 aut | |
| 700 | 1 | |a Olsson, Karen M. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Preston, Ioana R. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Rosenkranz, Stephan |e VerfasserIn |4 aut | |
| 700 | 1 | |a Souza, Rogerio |e VerfasserIn |4 aut | |
| 700 | 1 | |a Waxman, Aaron B. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Perchenet, Loïc |e VerfasserIn |4 aut | |
| 700 | 1 | |a Strait, James |e VerfasserIn |4 aut | |
| 700 | 1 | |a Xing, Aiwen |e VerfasserIn |4 aut | |
| 700 | 1 | |a Manimaran, Solaiappan |e VerfasserIn |4 aut | |
| 700 | 1 | |a Wang, Xuelong |e VerfasserIn |4 aut | |
| 700 | 1 | |a Miller, Barry |e VerfasserIn |4 aut | |
| 700 | 1 | |a Cornell, Alexandra G. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Pena, Janethe de Oliveira |e VerfasserIn |4 aut | |
| 700 | 1 | |a Ghofrani, H. Ardeschir |e VerfasserIn |4 aut | |
| 700 | 1 | |a Humbert, Marc |e VerfasserIn |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t European clinical respiratory journal |d Järfälla : Co-Action Publishing, 2014 |g 65(2025), 5, Artikel-ID 2401424, Seite 1-15 |h Online-Ressource |w (DE-627)835146359 |w (DE-600)2834928-3 |w (DE-576)445498900 |x 2001-8525 |7 nnas |a Efficacy and safety of the activin signalling inhibitor, sotatercept, in a pooled analysis of PULSAR and STELLAR studies |
| 773 | 1 | 8 | |g volume:65 |g year:2025 |g number:5 |g elocationid:2401424 |g pages:1-15 |g extent:15 |a Efficacy and safety of the activin signalling inhibitor, sotatercept, in a pooled analysis of PULSAR and STELLAR studies |
| 856 | 4 | 0 | |u https://doi.org/10.1183/13993003.01424-2024 |x Verlag |x Resolving-System |z kostenfrei |3 Volltext |
| 856 | 4 | 0 | |u https://publications.ersnet.org/content/erj/65/5/2401424 |x Verlag |z kostenfrei |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20251104 | ||
| 993 | |a Article | ||
| 994 | |a 2025 | ||
| 998 | |g 112535801 |a Grünig, Ekkehard |m 112535801:Grünig, Ekkehard |d 910000 |d 950000 |d 950900 |d 50000 |e 910000PG112535801 |e 950000PG112535801 |e 950900PG112535801 |e 50000PG112535801 |k 0/910000/ |k 1/910000/950000/ |k 2/910000/950000/950900/ |k 0/50000/ |p 5 | ||
| 999 | |a KXP-PPN1940128145 |e 4795961042 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"recId":"1940128145","note":["Gesehen am 04.11.2025"],"name":{"displayForm":["Marius M. Hoeper, Mardi Gomberg-Maitland, David B. Badesch, J. Simon R. Gibbs, Ekkehard Grünig, Grzegorz Kopeć, Vallerie V. McLaughlin, Gisela Meyer, Karen M. Olsson, Ioana R. Preston, Stephan Rosenkranz, Rogerio Souza, Aaron B. Waxman, Loïc Perchenet, James Strait, Aiwen Xing, Solaiappan Manimaran, Xuelong Wang, Barry Miller, Alexandra G. Cornell, Janethe de Oliveira Pena, H. Ardeschir Ghofrani and Marc Humbert"]},"id":{"eki":["1940128145"],"doi":["10.1183/13993003.01424-2024"]},"language":["eng"],"type":{"media":"Online-Ressource","bibl":"article-journal"},"origin":[{"dateIssuedDisp":"6 May 2025","dateIssuedKey":"2025"}],"relHost":[{"pubHistory":["1.2014 -"],"recId":"835146359","note":["Gesehen am 29.05.20"],"disp":"Efficacy and safety of the activin signalling inhibitor, sotatercept, in a pooled analysis of PULSAR and STELLAR studiesEuropean clinical respiratory journal","physDesc":[{"extent":"Online-Ressource"}],"title":[{"title_sort":"European clinical respiratory journal","title":"European clinical respiratory journal"}],"part":{"volume":"65","pages":"1-15","text":"65(2025), 5, Artikel-ID 2401424, Seite 1-15","year":"2025","extent":"15","issue":"5"},"origin":[{"dateIssuedKey":"2014","publisher":"Co-Action Publishing","dateIssuedDisp":"2014-","publisherPlace":"Järfälla"}],"language":["eng"],"id":{"zdb":["2834928-3"],"issn":["2001-8525","1399-3003"],"eki":["835146359"]},"type":{"bibl":"periodical","media":"Online-Ressource"}}],"person":[{"role":"aut","given":"Marius","family":"Höper","display":"Höper, Marius"},{"role":"aut","given":"Mardi","family":"Gomberg-Maitland","display":"Gomberg-Maitland, Mardi"},{"family":"Badesch","display":"Badesch, David B.","given":"David B.","role":"aut"},{"role":"aut","display":"Gibbs, J. Simon R.","family":"Gibbs","given":"J. Simon R."},{"role":"aut","given":"Ekkehard","family":"Grünig","display":"Grünig, Ekkehard"},{"role":"aut","given":"Grzegorz","display":"Kopeć, Grzegorz","family":"Kopeć"},{"role":"aut","given":"Vallerie V.","display":"McLaughlin, Vallerie V.","family":"McLaughlin"},{"family":"Meyer","display":"Meyer, Gisela","given":"Gisela","role":"aut"},{"family":"Olsson","display":"Olsson, Karen M.","given":"Karen M.","role":"aut"},{"given":"Ioana R.","family":"Preston","display":"Preston, Ioana R.","role":"aut"},{"role":"aut","display":"Rosenkranz, Stephan","family":"Rosenkranz","given":"Stephan"},{"role":"aut","display":"Souza, Rogerio","family":"Souza","given":"Rogerio"},{"role":"aut","family":"Waxman","display":"Waxman, Aaron B.","given":"Aaron B."},{"role":"aut","family":"Perchenet","display":"Perchenet, Loïc","given":"Loïc"},{"role":"aut","display":"Strait, James","family":"Strait","given":"James"},{"given":"Aiwen","display":"Xing, Aiwen","family":"Xing","role":"aut"},{"role":"aut","display":"Manimaran, Solaiappan","family":"Manimaran","given":"Solaiappan"},{"given":"Xuelong","display":"Wang, Xuelong","family":"Wang","role":"aut"},{"role":"aut","given":"Barry","family":"Miller","display":"Miller, Barry"},{"role":"aut","display":"Cornell, Alexandra G.","family":"Cornell","given":"Alexandra G."},{"family":"Pena","display":"Pena, Janethe de Oliveira","given":"Janethe de Oliveira","role":"aut"},{"display":"Ghofrani, H. Ardeschir","family":"Ghofrani","given":"H. Ardeschir","role":"aut"},{"role":"aut","family":"Humbert","display":"Humbert, Marc","given":"Marc"}],"title":[{"title":"Efficacy and safety of the activin signalling inhibitor, sotatercept, in a pooled analysis of PULSAR and STELLAR studies","title_sort":"Efficacy and safety of the activin signalling inhibitor, sotatercept, in a pooled analysis of PULSAR and STELLAR studies"}],"physDesc":[{"extent":"15 S.","noteIll":"Diagramme"}]} | ||
| SRT | |a HOEPERMARIEFFICACYAN6202 | ||